Joseph M. Busky - 27 May 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Financial Officer, Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky
Issuer symbol
QDEL
Transactions as of
27 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 17:31:43 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Stock Options Award $0 +21,012 $0.000000 21,012 27 May 2022 Common Stock 21,012 $119.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
F2 7,003 shares will vest on July 7, 2022 and 7,006 shares will vest on July 7, 2023.